Connection

Guido Antonelli to Humans

This is a "connection" page, showing publications Guido Antonelli has written about Humans.
Connection Strength

0.156
  1. COVID-19 infodemics: the role of mainstream and social media. Clin Microbiol Infect. 2021 Nov; 27(11):1568-1569.
    View in: PubMed
    Score: 0.008
  2. SARS-CoV-2 diagnostics: Some reflections on current assays. Diagn Microbiol Infect Dis. 2021 Feb; 99(2):115237.
    View in: PubMed
    Score: 0.007
  3. SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period. J Med Virol. 2021 02; 93(2):886-891.
    View in: PubMed
    Score: 0.007
  4. No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy. J Cyst Fibros. 2020 09; 19(5):837-838.
    View in: PubMed
    Score: 0.007
  5. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients. J Clin Virol. 2020 07; 128:104450.
    View in: PubMed
    Score: 0.007
  6. The SARS-CoV-2 epidemic: how the Italian public is being informed. Clin Microbiol Infect. 2020 Jun; 26(6):791-792.
    View in: PubMed
    Score: 0.007
  7. Virology: a scientific discipline facing new challenges. Clin Microbiol Infect. 2019 Feb; 25(2):133-135.
    View in: PubMed
    Score: 0.006
  8. Future management of viral diseases: role of new technologies and new approaches in microbial interactions. Clin Microbiol Infect. 2019 Feb; 25(2):136-141.
    View in: PubMed
    Score: 0.006
  9. Respiratory syncytial virus. Minerva Pediatr. 2018 Dec; 70(6):553-565.
    View in: PubMed
    Score: 0.006
  10. John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy. New Microbiol. 2018 07; 41(3):179-186.
    View in: PubMed
    Score: 0.006
  11. Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome. Cytokine Growth Factor Rev. 2018 04; 40:19-31.
    View in: PubMed
    Score: 0.006
  12. Consolidation of molecular testing in clinical virology. Expert Rev Anti Infect Ther. 2017 04; 15(4):387-400.
    View in: PubMed
    Score: 0.006
  13. Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals. Clin Microbiol Infect. 2016 Oct; 22(10):824-825.
    View in: PubMed
    Score: 0.005
  14. Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis. Virus Res. 2012 May; 165(2):236-40.
    View in: PubMed
    Score: 0.004
  15. Severe acute respiratory syndrome coronavirus elicits a weak interferon response compared to traditional interferon-inducing viruses. Intervirology. 2008; 51(4):217-23.
    View in: PubMed
    Score: 0.003
  16. Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy. J Med Virol. 2007 Apr; 79(4):463-8.
    View in: PubMed
    Score: 0.003
  17. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antivir Ther. 2004 Dec; 9(6):1003-11.
    View in: PubMed
    Score: 0.002
  18. Treatment of SARS with human interferons. Lancet. 2003 Oct 04; 362(9390):1158; author reply 1158-9.
    View in: PubMed
    Score: 0.002
  19. ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? Cytokine. 2021 04; 140:155430.
    View in: PubMed
    Score: 0.002
  20. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19). Virus Res. 2021 04 02; 295:198283.
    View in: PubMed
    Score: 0.002
  21. SARS-CoV-2 infection: diagnostic testing results occasionally require special attention. Emerg Microbes Infect. 2020 Dec; 9(1):1955-1957.
    View in: PubMed
    Score: 0.002
  22. Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital. Int J Antimicrob Agents. 2021 Jan; 57(1):106245.
    View in: PubMed
    Score: 0.002
  23. Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro. Pharmacol Res. 2021 01; 163:105255.
    View in: PubMed
    Score: 0.002
  24. Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive? J Clin Virol. 2020 12; 133:104660.
    View in: PubMed
    Score: 0.002
  25. What is the optimal usage of coronavirus disease 2019 convalescent plasma donations? Clin Microbiol Infect. 2021 Feb; 27(2):163-165.
    View in: PubMed
    Score: 0.002
  26. COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome. Acta Haematol. 2020; 143(6):574-582.
    View in: PubMed
    Score: 0.002
  27. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report. Medicine (Baltimore). 2020 Sep 04; 99(36):e21803.
    View in: PubMed
    Score: 0.002
  28. Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease. J Glob Antimicrob Resist. 2020 12; 23:67-69.
    View in: PubMed
    Score: 0.002
  29. SARS-CoV-2 presence in seminal fluid: Myth or reality. Andrology. 2021 01; 9(1):23-26.
    View in: PubMed
    Score: 0.002
  30. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators. J Virol. 2019 11 01; 93(21).
    View in: PubMed
    Score: 0.002
  31. Merkel Cell Polyomavirus DNA Detection in Respiratory Samples: Study of a Cohort of Patients Affected by Cystic Fibrosis. Viruses. 2019 06 21; 11(6).
    View in: PubMed
    Score: 0.002
  32. Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence. J Med Virol. 2022 02; 94(2):491-498.
    View in: PubMed
    Score: 0.002
  33. Low prevalence of Gemycircularvirus DNA in immunocompetent and immunocompromised subjects. New Microbiol. 2019 Apr; 42(2):118-120.
    View in: PubMed
    Score: 0.002
  34. Increased expression of IL-32 correlates with IFN-?, Th1 and Tc1 in virologically suppressed HIV-1-infected patients. Cytokine. 2019 08; 120:273-281.
    View in: PubMed
    Score: 0.002
  35. Increased IL-17 and/or IFN-? producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women. AIDS. 2019 03 15; 33(4):627-636.
    View in: PubMed
    Score: 0.002
  36. How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis. J Infect Dis. 2019 01 29; 219(4):526-534.
    View in: PubMed
    Score: 0.002
  37. Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation. J Immunol Res. 2018; 2018:1738676.
    View in: PubMed
    Score: 0.002
  38. Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. Clin Microbiol Infect. 2019 Apr; 25(4):474-480.
    View in: PubMed
    Score: 0.002
  39. Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity. J Clin Virol. 2018 05; 102:101-109.
    View in: PubMed
    Score: 0.002
  40. Interferon lambda4 polymorphism is not associated with human papillomavirus infection outcome. Virus Genes. 2018 Apr; 54(2):319-322.
    View in: PubMed
    Score: 0.001
  41. Acute bronchiolitis: Influence of viral co-infection in infants hospitalized over 12 consecutive epidemic seasons. J Med Virol. 2018 04; 90(4):631-638.
    View in: PubMed
    Score: 0.001
  42. Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infect Dis. 2017 08 22; 17(1):581.
    View in: PubMed
    Score: 0.001
  43. Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors. J Glob Antimicrob Resist. 2017 09; 10:106-112.
    View in: PubMed
    Score: 0.001
  44. Respiratory syncytial virus bronchiolitis, weather conditions and air pollution in an Italian urban area: An observational study. Environ Res. 2017 10; 158:188-193.
    View in: PubMed
    Score: 0.001
  45. Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper. Clin Microbiol Infect. 2017 Dec; 23(12):935-940.
    View in: PubMed
    Score: 0.001
  46. Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review. Clin Microbiol Infect. 2017 Dec; 23(12):916-923.
    View in: PubMed
    Score: 0.001
  47. Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. Immun Inflamm Dis. 2017 09; 5(3):244-260.
    View in: PubMed
    Score: 0.001
  48. Rhinovirus species/genotypes and interferon-?: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma? Eur Respir J. 2017 03; 49(3).
    View in: PubMed
    Score: 0.001
  49. Bronchiolitis: Analysis of 10 consecutive epidemic seasons. Pediatr Pulmonol. 2016 12; 51(12):1330-1335.
    View in: PubMed
    Score: 0.001
  50. Investigation on torquetenovirus (TTV) microRNA transcriptome in vivo. Virus Res. 2016 06 02; 217:18-22.
    View in: PubMed
    Score: 0.001
  51. Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients. Infection. 2014 Dec; 42(6):1033-7.
    View in: PubMed
    Score: 0.001
  52. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child. 2010 Jan; 95(1):35-41.
    View in: PubMed
    Score: 0.001
  53. Physiological mechanisms of production and action of interferons in response to viral infections. Adv Exp Med Biol. 1989; 257:47-60.
    View in: PubMed
    Score: 0.001
  54. Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection. J Virol. 2001 Dec; 75(24):11999-2004.
    View in: PubMed
    Score: 0.000
  55. A macrophage derived blastogenic factor -MBF- induces cytokines and cytotoxic effectors in human peripheral blood mononuclear cells. J Biol Regul Homeost Agents. 1992 Jan-Mar; 6(1):8-14.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.